The website is: https://stocknessmonster.com/quotes/osx.asx/
As you have seen Michael Liew and The Rain Maker group (both fund managers, Michael is from Argo Capital) have been selling, mostly on market. They are both in the T5, given no change in business fundamentals I can only suspect they see better prospects elsewhere or needed the money. Given they are both fund managers/groups, it would not surprise me if games are being played.
From a fundamentals perspective this is starting to get into oversold territory, with $9M in the bank and I would take a stab at the intellectual property value of around $5-10M, add in revenue projections at around ~$3M, anything lower than 50c ($30M EV) is starting to get silly.
OSX has over 10years clinical data on it's efficacy and all regulatory approvals in place, the commercialization journey has only just started. The upside is huge. Any new players in this space are years behind our progression. We in a $4B TAM with a viable product just starting its commercialization path.
This is a great video on what's being achieved with Osteopore's technology:
Add to My Watchlist
What is My Watchlist?
